Store-operated calcium entry contributes to abnormal Ca<sup>2+</sup> signalling in dystrophic mdx mouse myoblasts by Onopiuk, Marta et al.
*Revised Manuscript (Unmarked)  
Click here to view linked References  
1  
Store-operated calcium entry contributes to abnormal Ca2+ signalling in dystrophic mdx 
mouse myoblasts  
 
Marta Onopiuk2,4,*, Wojciech Brutkowski1,2,*, Christopher Young1, Elżbieta Krasowska1,2 
Justyna Róg2, Morten Ritso3, Sylwia Wojciechowska2, Stephen Arkle1, Krzysztof Zabłocki2#$ and 
Dariusz C. Górecki1#.  
1School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK; 
2Nencki Institute of Experimental Biology, Warsaw, Poland;  
3Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, UK.  
4 Present address: Departments of Cell Biology, University of Oklahoma Health Sciences Center, 
Oklahoma City, Oklahoma, USA  
 
* equal participation; # senior co-authors  
 
$Corresponding author: K. Zabłocki, Nencki Institute of Experimental Biology, 3 Pasteura str. 02- 
093 Warsaw, Poland; e-,ail: k.zablocki@nencki.gov.pl  
 
 
Keywords: Duchenne muscular dystrophy; mdx; myoblasts; store-operated calcium entry, STIM1  
protein  
 
 
Abbreviations: [Ca2+]c, cytosolic Ca2+ concentration; DMD, Duchenne muscular dystrophy; DMEM, 
Dulbecco’s  modified  Eagles’  medium;  ER,  endoplasmic  reticulum;  NCX,  sodium/calcium 
exchanger; SOCE, store-operated Ca2+ entry; STIM1, stromal interaction molecule 1;TRPC, transient 
receptor potential channel canonical;  
 
 
2  
 
ABSTRACT  
 
Sarcolemma damage and activation of various calcium channels are implicated in altered Ca2+  
homeostasis in muscle fibres of both Duchenne muscular dystrophy (DMD) sufferers and in the mdx  
mouse model of DMD. Previously we have demonstrated that also in mdx myoblasts extracellular  
nucleotides trigger elevated cytoplasmic Ca2+ concentrations due to alterations of both ionotropic and  
metabotropic purinergic receptors. Here we extend these findings to show that the mdx mutation is  
associated with enhanced store-operated calcium entry (SOCE). Substantially increased rate of SOCE  
in mdx myoblasts in comparison to that in control cells correlated with significantly elevated STIM1  
protein  levels.  These  results  reveal  that  mutation  in  the  dystophin-encoding  Dmd  gene  may  
significantly impact cellular calcium response to metabotropic stimulation involving depletion of the  
intracellular calcium stores followed by activation of the store-operated calcium entry, as early as in  
undifferentiated myoblasts. These data are in agreement with the increasing number of reports showing  
that the dystrophic pathology resulting from dystrophin mutations may be developmentally regulated.  
Moreover, our results showing that aberrant responses to extracellular stimuli may contribute to DMD  
pathogenesis suggest that treatments inhibiting such responses might alter progression of this lethal  
disease.  
 
1.  Introduction  
Duchenne muscular dystrophy (DMD) is an incurable disorder caused by mutations in the DMD gene  
encoding dystrophin. Dystrophin localises to the cytoplasmic face of the muscle fibre sarcolemma  
and anchors a group of proteins known as the dystrophin-associated protein (DAP) complex to actin  
filaments and microtubules [1, 2]. These interactions provide a link between the cytoskeleton, DAP  
complex in the cell membrane  and the extracellular matrix components bound by DAP and has a role  
in mechanical strengthening of the sarcolemma during the contractile activity [1]. While disruption of  
this link certainly contributes to DMD pathology, additional pathogenic mechanisms are also  
involved and include an abnormal calcium homeostasis; the cytosolic calcium ([Ca2+]c) concentration  
is raised in the subsarcolemmal region of dystrophic muscle cells and this cannot be explained by  
membrane ruptures alone [3]. This is particularly true in myoblast, which are non-excitable cells and  
do not have contractile apparatus, thus a rupture of their sarcolemma due to mechanical stress typical  
for differentiated muscle cells is not likely.  
In our earlier studies we have shown that mutations of the dystophin gene exert a previously  
unrecognized effect on nucleotide-induced calcium responses in undifferentiated muscle cells.  
Exposure of the dystrophic (mdx) mouse myoblasts to extracellular ATP triggers a significant  
increase in [Ca2+]c, with both P2X and P2Y receptors involved. Probing the P2X (ionotropic) arm of  
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this abnormal purinergic response we identified P2RX7 as the main receptor responsible [4,5] and also 
discovered a novel mechanism of autophagic cell death evoked by activation of the P2RX7 large pore 
specifically in dystrophic myoblasts [6].  
Stimulation of metabotropic P2Y receptors coupled with Gq protein initiates a signalling pathway,  
involving an activation of phospholipase C and increase of IP3 concentration, which activates Ca2+  
release from the intracellular calcium stores in the sarcoplasmic reticulum. The latter is prerequisite  
for activation of store-operated calcium entry (SOCE); a depletion of the intracellular calcium stores  
activates Ca2+ entry from the extracellular milieu. The phenomenon of store-operated Ca2+ entry was  
discovered in the mid- 80’s of the last century but the true mechanism of this process was not clarified  
until 20 years later [7, 8]. Among proteins involved in activation and regulation of SOCE, the two  
most prominent are STIM1 and Orai1. STIM1 spans the ER membrane and, thanks to the ER-hand  
domain located in the lumen of the ER cistern, senses Ca2+ concentration in stores. Depletion of the  
ER of calcium results in a horizontal movement of STIM1 in the ER membrane, its clustering and  
then interaction with the plasma membrane channel-forming protein Orai1. This, finally, results in  
Ca2+ entry into the cell. Replenishment of Ca2+ stores breaks these molecular interactions and stops  
Ca2+ influx [9, 10]. Furthermore, participation of different proteins of the TRP-family in activation of  
various routes of Ca2+ entry, including in SOCE, was also suggested [11, For review see: 12].  
Given that our data indicated an abnormal calcium response of mdx myoblasts following stimulation  
of P2Y receptors [4] we decided to study whether this may, at least partially, result from up-regulation  
of SOCE. We have found a significantly increased activity of SOCE in mdx myoblasts, which was  
accompanied by increased levels of STIM1 protein. Interestingly, the expression of Orai1 protein was  
unchanged in these cells. Similarly, changes in the TRPC proteins levels could not explain accelerated  
Ca2+ entry upon depletion of the ER stores. While increased activity of SOCE in dystrophic myofibers  
was described earlier [13] the importance of data presented here stems from the fact that myoblasts, as  
undifferentiated muscle cells, do not produce the full-length dystophin protein at levels detectable by  
Western blot despite clearly expressing the full-length transcript. Thus, abnormalities in susceptibility  
to ATP described previously [4,5] as well as in the activity of store-operated calcium entry described  
here imply that focal dystrophin or its transcript alone may have a function. Its absence in Duchenne  
muscular dystrophy triggers an additional pathological mechanisms leading to an aberrant calcium  
homeostasis as early as in myoblasts. Understanding these processes may offer new therapeutic  
opportunities for the management of this lethal pathology.  
 
2. Materials and methods  
2.1. Cell culture  
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The mdx mouse and dystrophin-positive C57Bl10 myoblast cell lines were used. These two cell lines  
were derived from the “immorto mouse” or H2Kb-tsA58 line [14] and tested for their muscle  
phenotype and for myogenic potential following differentiation [5, 15, 16,]. Cells were cultured in  
Dulbecco’s modified Eagles’ medium (DMEM) supplemented with 20% foetal calf serum (FCS), 4  
mM L-glutamine, 100 unit/ml penicillin, 100 g/ml streptomycin, and 20 unit/ml murine -interferon  
(Invitrogen, San Diego, CA,USA) at 33°C in a 95% air, 5% CO2 atmosphere. When the cells reached  
95% of confluence their myogenic properties could be confirmed by their ability to differentiation  
into myotubes. It was induced by changing the growth medium to the differentiation one containing  
2% horse serum (HS) instead of FCS and depleted of -interferon and incubation at 37°C. Myotubes  
were examined after 3-6 days in culture. All media and reagents were purchased from Sigma (Poole,  
UK).  
 
2.2. Primary myoblast culture  
Mice were used with the approval of the local ethics commission (Polish Law on the Protection of  
Animals). Satellite cells were prepared from hindlimb muscle of control (C57BL/10ScSnJ) and  
dystrophic (C57BL/10ScSn-Dmd<mdx>/J) adult (2-3 month-old) male mice (Jackson Laboratory,  
Jacksonville, USA). Isolation and purification of satellite cells from tibialis anterior (TA) and soleus  
(Sol) muscles and myoblast culture procedures were performed as described in [17]. Briefly, whole  
muscles were sterilized in PBS with betadine and iodine and then digested with 0.2% collagenase  
type I in DMEM for 1.5 h at 37°C, rinsed in DMEM supplemented with 1 g/l glucose, 1 mM  
pyruvate, 4 mM L-glutamine, 10% HS, 0.5% chicken embryo extract (CEE), 1000 U/l penicillin  
(1000 U/l) and 1 mg/l streptomycin and triturated with pipettes of gradually decreasing diameter.  
Entire fibres were separated, rinsed four times with the same medium and finally transferred into  
DMEM (composition as above, supplemented with 20% FBS). Purified fibres were dispersed by  
forcing through an 18 guage injection needle, filtered through 40 m pore diameter nylon bolting  
cloth, put into collagen-coated culture dishes and incubated in the same medium at 37°C in  
humidified atmosphere of air (95%) and  CO2 (5%) for 5 days.  
 
2.3. RT-PCR analysis  
Total  cellular  RNA  was  extracted  from  myoblasts  using  RNA  Isolation  System  (Promega,  
Southampton, UK) and 5 g of RNA were reverse transcribed using random hexamers and the  
Superscript First Strand Synthesis System (Fisher). Reverse transcriptase was omitted in negative  
control samples. RT-PCR was performed with primer sets specific for STIM1 transcripts: Fv: 5’- 
TGCTGTTTGGGCCTCCTCTC-3’ and Rev: 5’-CCTCCACCTCATGGGTCAGC-3’ based on [18].  
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PCR conditions for amplification were 94°C for 4 min, followed by 35 cycles of 94°C for 60 s, 58°- 
60oC for 60 s, 72°C for 60 s with a final extension step of 72°C for 7 min. The identity of the 
amplicons was confirmed by sequencing and restriction analysis. Semi-quantitative analyses of 
STIM1 expression were performed essentially as previously described [5]. All experiments were 
repeated at least 3 times and performed in triplicate.  
 
2.4. Protein extraction and analysis  
Proteins were extracted from adherent cells by scraping into extraction buffer  (1x LysisM, 1x  
protease  inhibitor  cocktail,  2  x  phosphatase  inhibitor  cocktail  (all  Roche),  2  mM  sodium  
orthovanadate (Sigma) suspending with the use of automatic pipets and incubation of this suspension  
on ice for 20 min. After centrifugation (15 000 x g, for 20 min at 4oC) protein concentrations in  
supernatants collected were determined using a bicinchoninic acid assay kit (Sigma). Remaining  
supernatants were mixed with sample buffer at 3:1 v/v ratio, heated for 5 min at 95
C and chilled on  
ice and stored at -80oC. Proteins were separated on SDS-polyacrylamide gels (6-12% w/v depending  
on the molecular mass of protein) and electroblotted onto Hybond C membranes (Amersham, UK).  
Blots were blocked in 5% w/v non-fat milk powder in 1x TBST, 0.01% v/v Tween-20 (Sigma) for 1h  
prior to probing with appropriate primary antibody (for STIM1, NCX, SERCA1 and 2 from  
Alomone, or TRPC1, TRPC3 and TRPC6 from Abcam) or   diluted in a blocking buffer containing  
2% milk (for 1h at RT) then washed (3x) with 1x PBST for 10 min and incubated with the  
appropriate horseradish peroxidase-conjugated secondary antibody (Sigma) for 1h.  Specific protein  
bands were visualized using luminol-based substrates (Uptilight US, Cheshire Sciences) and images  
obtained using a G- BOXChemi XT-16 system (Syngene). -actin antibody (Sigma) was used as a  
protein-loading control. Densitometric analyses of specific protein bands were made using exposure  
times within the linear range and the integrated density measurement function of Image J software.  
All experiments were repeated at least 3 times with similar results obtained in each replicate.  
 
2.5. [Ca2+]c measurements in myoblasts in vitro  
Myoblasts were cultured on glass coverslips in a 6-well plate (500,000 cells/well) for 48 h under  
conditions described above. Cells (70-80% confluent) were loaded with 1 M Fura 2 AM (Molecular  
Probes, Oregon) in culture medium for 15 min at 33°C (in a case of immortalized cells) or with 2 M  
Fura 2AM diluted with the serum-depleted growth medium for 25 min at 37°C (primary myoblasts)  
in a humidified atmosphere of 95% O2 and 5% CO2. The cells were then washed twice with the  
solution composed of 5 mM KCl, 1 mM MgCl2, 0.5 mM Na2HPO4, 25 mM HEPES, 130 mM NaCl,  
1 mM pyruvate, 5 mM D-glucose, and 0.1 mM CaCl2, pH 7.4 and the coverslips were mounted in a  
cuvette containing 3 ml of either the nominally Ca2+-free assay solution (as above but 0.1 mM CaCl2  
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was replaced by 0.05 mM EGTA) or Ca2+-containing assay solution (as above but with 2 mM CaCl2) and 
maintained at RT in a spectrofluorimeter (Shimadzu, RF5001PC).  
Fluorescence was recorded at 510 nm with excitation at 340 and 380 nm. At the end of each  
experiment the Fura 2 fluorescence was calibrated by addition of 8 M ionomycin to determine  
maximal fluorescence followed by addition of EGTA to complete removal of Ca2+. Cytosolic Ca2+  
concentration [Ca2+]c was calculated according to Grynkiewicz et al. [19]. The cells were treated  
with: 1 mM ATP (a P2 agonist); 1 µM Coomassie Brilliant Blue G 250 (CBB - a P2X7 antagonist  
applied 10 min prior to the addition of ATP); 1 M thapsigargin (SERCA inhibitor). Each  
experiment was repeated at least 5 times.  
 
2.7. Analysis of results  
Data are expressed as a mean value ± standard deviation (SD). Statistical significance was assessed by  
Student’s t-test A p value of <0.05 was considered statistically significant where n=3-5 for PCR and  
Western data, and n=3-9 for other analyses. In the case of immortalised myoblasts “n” represents the  
number of independent experiments with cells derived from different passages. In the case of primary  
myoblasts it refers to the number of experiments with cells derived from different “n” animals (i.e.  
biological replicates).  
 
 
2.  Results  
 
3.1 Myoblast calcium response to stimulation with nucleotides  
We have analysed functional differences in store-operated calcium entry between wild-type (w/t) and  
dystrophic mouse myoblasts. These cells have been extensively characterized previously [5, 16,] and  
show myogenic characteristics upon differentiation (Fig 1).   Stimulation of myoblasts placed in the  
calcium-free buffered salt solution with 1 mM ATP resulted in an immediate increase in cytosolic  
Ca2+ (Fig. 2A). This reflects calcium release from the intracellular stores, due to activation of a P2Y- 
evoked and protein G-mediated signalling pathway. More pronounced response in mdx myoblasts  
may suggest higher susceptibility of dystrophic cells to such an excitation than one shown by control  
myoblasts. Similar treatment of cells in the presence of extracellular Ca2+ also causes more intensive  
increase in cytosolic Ca2+ in mdx cells (Fig. 2B). In this case, increase in the cytosolic Ca2+  
concentration may correspond not only to depletion of the ER stores but also to activated capacitive  
Ca2+ entry into cells, secondary to the calcium release. Moreover, ATP could, at least potentially,  
activate Ca2+ influx due to activation of ionotropic receptors belonging to the P2X family. However,  
as we have previously shown, the only functional receptor active in these cells being P2X7, it can be  
fully inhibited by CBB [4]. Thus, preincubation of cells with this inhibitor allowed selective  
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activation of metabotropic receptors and permitted distinguishing their responses from those of 
ionotropic ones (Fig. 2B). The important question, which of the P2Y receptor(s) is specifically 
responsible for the increased release of Ca2+ from intracellular stores in dystrophic myoblasts is 
currently unanswered. Nevertheless, stimulation of each of those cooperating with PLC in a G 
protein-mediated manner can activate similar chain of events involving depletion of intracellular 
calcium stores and subsequent activation of store-operated calcium entry (SOCE). Thus, receptor 
identity notwithstanding, the question arises whether enhanced Ca2+ influx into mdx myoblasts may, and 
to what extent, involve dystrophy-evoked stimulation of store-operated calcium entry as a second 
component of the cellular calcium response upon metabotropic stimulation of purinergic receptors. 
Therefore, subsequent experiments were focused on this question.  
 
3.2. Alteration of store operated mechanisms in dystrophic myoblasts  
To answer this question, cells placed in the calcium-free solution were treated with thapsigargin to  
irreversibly inhibit SERCA and completely deplete intracellular calcium stores. After depletion of the  
ER calcium stores and establishment of the cytosolic Ca2+ concentration at a stable level under  
calcium-free conditions, the assay medium was supplemented with 2 mM CaCl2. Such approach  
allowed skipping first steps of cell activation (comprising of receptor stimulation, PLC activation,  
and IP3 formation and Ca2+ release from the stores) and permitted investigating calcium entry  
independently of any primary extracellular stimulus and receptor activation. Thapsigargin-evoked  
total depletion of the ER calcium stores results in maximal activation of SOCE. Changes of  
fluorescence measured using the Fura-2 probe allow estimating the rate of Ca2+ entry seen as an  
initial slope of the curve representing increase in cytosolic Ca2+ concentration immediately after the  
addition of CaCl2 into the assay. Using this approach we minimize any influence of other processes,  
which may affect an increase of cytosolic Ca2+ concentration as a direct result of accelerated Ca2+  
entry As shown in Fig 3A and B we have found that Ca2+ entry into mdx cells was substantially faster  
than into respective w/t myoblast. It should be emphasized that an addition of CaCl2 into the assay  
without preincubation of cells with thapsigargin was not followed by any Ca2+ influx to either w/t or  
mdx myoblasts (not shown). This excludes unspecific Ca2+ influx, which could affect thapsigargin- 
induced store-operated calcium.   Moreover, the maximal Ca2+ concentration reached much higher  
levels in mdx then in control cells. However, this value may be strongly affected by processes  
lowering cytosolic Ca2+ concentrations because it delimits a point of equilibrium between calcium  
influx into and efflux from a cell. In addition, a feed-back inhibition of store-operated calcium  
channels by Ca2+ accumulated beneath the plasma membrane must be considered. Therefore,  
comparisons of the maximal values of calcium transients in control and dystrophic myoblasts do not  
seem to be a reliable measure of SOCE activity. This seems particularly remarkable in the view of  
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data shown in Fig. 3D indicating evidently enhanced levels of Na+/Ca2+ exchanger (NCX), which is  
responsible for Ca2+ extrusion and recovery of the [Ca2+]c resting level. This suggests that the value  
of [Ca2+]c peak in mdx myoblasts might, in fact, be underestimated. In other words, the Ca2+ entry- 
counteracting process may be more efficient in the mdx then in the w/t cells.  Actually, more precise  
analysis of traces derived from 15 independent experiments (one example shown in Fig. 3A) has  
revealed that the half-time of recovery of the cytosolic Ca2+ concentration to the new steady state is  
significantly shorter and that Ca2+ is removed much faster   in mdx then in w/t myoblasts (Fig. 4).  
Moreover, mdx and w/t myoblasts differ in their response to thapsigargin. As shown in Fig. 3A, faster  
increase of the cytosolic Ca2+ concentration following addition of thapsigargin in mdx myoblasts may  
be correlated with significantly increased SERCA1 and SERCA2 protein levels (Fig. 3E and F),  
which may suggest more calcium being accumulated initially. Unchanged levels of IP3 receptor in  
mdx cells (Fig. 3C) do not allow attributing faster Ca2+ release to this protein. On the other hand,  
much faster decay of the Ca2+ transient to the basal level may reflect increased amount of NCX  
exchanger. Pre-treatment of cells with thapsigargin results in complete depletion of the ER stores and  
maximal activation of SOCE. Thus, differences in SERCA level did not seem to interfere with Ca2+  
entry into cells, particularly as CaCl2 was added into the assay buffer as soon as a new (very low and  
identical in both cell lines) basal concentration of Ca2+ was established. It should also be stressed that  
calcium release upon treatment of cells with thapsigargin is relatively slow. Therefore, the heights of  
[Ca2+]c peak do not allow estimating the amount of calcium stored because changes in cytosolic Ca2+  
concentrations are strongly influenced by the process of calcium removal. One likely explanation for  
the observed difference concerning rate of calcium entry upon supplementation of the assay with  
CaCl2 could be that dystrophic cells exhibit more active SOCE due to higher levels of proteins  
crucially involved in this process. This possibility we studied using Western blotting analysis of  
major proteins participating in SOCE: STIM1 and Orai1. Furthermore, amounts of TRPC1, TRPC3  
and TRPC6 (other proteins believed to participate in SOCE) were also tested in both w/t and mdx  
myoblasts. As shown in Fig. 5A, STIM1 protein levels in mdx myoblasts were substantially higher  
than it w/t cells. Similar phenomenon was observed at later stages of  differentiation in healthy and  
dystrophic muscles [13]. On the other hand, semi-quantitative PCR assay has nor revealed any  
noticeable differences between the STIM1 transcript content in both cell lines used in this study (Fig.  
5C). We also found that the total level of Orai1 protein was the same in both cell lines tested (Fig. 6).  
This observation is contrary to the data from differentiated muscle cells and indicate important  
differences in cellular calcium homeostasis during maturation of w/t and dystrophic muscles [13].  
Also amount of  TRPC1 and TRPC3 proteins, which are postulated to be involved in abnormal Ca2+  
homeostasis in dystrophic adult muscle fibres [ 20,21,22] were unchanged or only insignificantly  
lowered in mdx myoblasts, while TRP6 protein content in dystrophic myoblasts was reduced  
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substantially (Fig. 6B).   In summary, these data suggest that, Orai1 and TRPC1, 3 and 6 proteins  
seem not responsible for stimulated Ca2+ entry into mdx myoblasts, due to their unchanged or even  
reduced (TRPC6) expression in mdx myoblasts. However, an increased activity/altered distribution of  
these proteins despite their unaltered/reduced levels could not be definitely excluded.  
To exclude cell-line specific effects, the experiments were repeated in a second set of immorto mdx  
and w/t cells (independently derived from different lines of H2Kb-tsA58 w/t and mdx mice) and the  
same responses were found.  
Furthermore, to exclude the possibility that some of the effects were due to cell immortalization,  
primary myoblasts isolated from mdx and w/t tibialis anterior and soleus muscles were analysed to  
study the thapsigargin-induced Ca2+ entry (Fig. 6A and B). Also in this case, significant up-regulation  
of SOCE correlated with increased levels of STIM1 protein in dystrophic myoblasts isolated from  
these two different muscle groups (Fig 6C).Unfortunately, high fragility of the primary myoblasts  
even grown on specially coated surfaces, forced us to modify the assay in order to keep its time as  
short as possible following the addition of thapsigargin used for depletion of the ER calcium stores.  
Nevertheless, differences between rates of Ca2+  entry were evident irrespective of not always  
completely reaching a steady state prior to addition of CaCl2. Importantly, preincubation of  
myoblasts with 2-APB, commonly used inhibitor of SOCE [23], abolished Ca2+ entry into both wt  
and mdx cells isolated from tibialis anterior, thus finally confirming participation of SOCE in the  
observed Ca2+ entry (data not shown).  In summary, findings in primary muscle cells confirmed the  
aforementioned data in myoblast lines and ruled out the possibility that the up-regulation of SOCE in  
immortalized mdx myoblasts was an artefact of cell modifications.  
 
3.  Discussion  
Paracrine or autocrine stimulation of muscle cells with ATP, which is released in small amounts in  
response to skeletal muscle physiological activity, modulates Ca2+ homeostasis and muscle plasticity  
via activation of P2 receptors [24]. However, although first indications of the functional significance  
of ATP receptors in skeletal muscle cells emerged in 1983 [25], our understanding of the roles of  
specific P2 receptors in this tissue started emerging only recently. It is beyond any doubts that Gq- 
linked nucleotide receptors are involved in muscle cell differentiation, regeneration and motility [26  
27, 28, 29, 30 (and references cited herein)]. Interestingly, several P2 receptors were found  
differentially expressed in muscles at different stages of DMD pathology [30, 31]. Moreover,  
enhanced Ca2+  entry into dystrophic myofibers due to activation of various Ca2+  channels and  
transport mechanisms has been described repeatedly [13, 32]. Such abnormalities are believed to be a  
result of impaired scaffolding of membrane proteins involved in Ca2+ signaling due to the absence of  
dystrophin-associated protein complexes [33].  These observations have been expanded by us and  
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others showing that mutations in dystrophin gene closely correlate with alteration of ATP signaling and 
that this abnormality affects myoblasts [4, 5] and lymphoblasts [34]. While convincing  
identification of Gq-linked P2Y receptor(s) producing the ATP-evoked abnormal Ca2+ increases in 
dystrophic myoblasts requires further studies, an enhanced metabotropic response to nucleotide 
stimulation is beyond any doubt.  
We have found that the metabotropic purinergic response was significantly higher in dystrophic  
versus control cells both in the absence and in the presence of extracellular Ca2+ but in the latter case  
the relative stimulatory effect was more pronounced (see Fig. 2). This observation indicated that mdx  
myoblasts are more susceptible not only to nucleotide-induced Ca2+ release, but also that Ca2+ influx  
from the extracellular milieu, secondary to the Ca2+ release from the ER, is more effective in these  
cells.  
Increased SOCE activity may contribute to cellular responses to numerous stimuli. Amongst these  
stimuli are nucleotides interacting with specific P2Y receptors. More abundant STIM1 protein found  
in dystrophic myoblasts compared to w/t cells partially explains the more intense calcium response in  
these cells when excited with nucleotides. On the other hand, enhanced Ca2+ release from the ER  
stores in mdx myoblasts stimulated with ATP in the absence of extracellular calcium clearly shows  
that SOCE per se is not the only over-activated component of metabotropic response in these cells.  
Undoubtedly however, SOCE participates in generation of abnormal calcium signals in dystrophic  
myoblasts exposed to multiple stimuli acting via depletion of the intracellular calcium stores.  
Enhanced SOCE into muscle fibres with the mutated dystrophin gene has been described previously.  
It was attributed to various mechanisms, including an impaired dystrophin/1-syntrophin scaffold  
formation [35] and increased STIM1 and Orai1 protein levels [13]. However, it must be stressed that  
these DMD studies were performed in differentiated muscle cells (myotubes and myofibers) and not  
in myoblasts used in our study, which are very different structurally and functionally.  
Previously, we have shown that mitochondrial membrane potential in dystrophic cells is higher than  
in controls [36].   This could imply more efficient mitochondrial buffering of calcium ions which  
reduces a feedback inhibition of SOCE by Ca2+ accumulated in the close vicinity of the calcium  
channels [37]. However, dissipating mitochondrial potential with protonophore (CCCP), although  
resulting in a substantial inhibition of SOCE, did not abolish the difference between w/t and  
dystrophic myoblasts (data not shown). It suggests that the cause of the observed difference lies  
elsewhere.  
In this study, the overstimulation of SOCE in dystrophic cells has been correlated with the increased  
STIM1 protein content. This difference was observed both between immortalized and primary  
dystophic and control myoblasts, thus excluding potential side-effect of immortalization. Therefore,  
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the more effective SOCE in dystrophic myoblasts could, at least to some extent, depend on 
differences in the levels of this crucial store-operated Ca2+channel protein.  
Interestingly, SOCE is of great importance in differentiating myoblasts and increasing levels of 
STIM1 correlate with accelerated muscle differentiation [38]. Consequently, it was shown that 
overexpression of STIM1 stimulates muscle cell differentiation, while silencing it inhibits this 
process [39]. Thus, it appears possible that the more active SOCE/higher STIM1 levels in dystrophic 
myoblasts reflect their higher “readiness” for differentiation described by others [40, 41] and also seen 
by us. Such over-activation of SOCE upon dystrophic cell stimulation might lead to cellular calcium 
overload and to increased susceptibility to cell death thus contributing to progressive muscle degeneration 
[43 (and references cited herein)].  
It remains to be tested whether the elevated NCX content in dystrophic cells shown here is 
accompanied by its higher activity and reflects a defence mechanism protecting these cells against 
excessive calcium  accumulation.  If so,  this mechanism  could  participate in  cell  adaptations 
enhancing their viability, as has been suggested elsewhere [42 (and references cited herein)]. In 
addition, substantially increased thapsigargin-induced SOCE rate in dystrophic mdx myoblasts could be 
underestimated because of the increased NCX levels in these cells.  
Significantly elevated STIM1 protein level has also been found in situ, in fully differentiated  
dystrophic muscle fibres from the extensor digitorum longus muscle [13]. We have extended this  
observation by finding increased STIM1 levels in myoblasts of two other mouse leg muscles: soleus  
and tibialis anterior. These data show the same pattern of dystrophy-induced changes in both  
undifferentiated myoblasts and fully matured muscle cells. Conversely, dystrophin deficiency was  
also found to be accompanied by increased amount of Orai1, the second crucial protein involved in  
SOCE [13] while data shown here does not confirm this effect. It may suggest that a profile of  
changes concerning molecules involved in shaping the intracellular calcium homeostasis during  
muscle differentiations is strongly dependent on mutations in the dystrophin gene.  
However, it must be stressed that while in differentiated muscle cells (myotubes and myofibers) the 
dystrophin protein presence was confirmed, in myoblasts used in our study, dystrophin protein is 
undetectable using standard Western blotting methods. Thus, an interpretation of the observed 
differences  implying  the  impaired  dystrophin-dependent  scaffold  formation  seems  to  be 
unsatisfactory. Several experiments addressing this problem could be envisaged.  
Considering the causative link between the disruption of the DAP complex or between DAP and its 
interacting proteins in dystrophic myotubes and the alteration of calcium homeostasis there, it has been 
shown that over-expression of mini- or full-length dystrophin improved calcium handling in cultured 
myotubes [43, 44].  It would be interesting to test whether expression of such mini-genes in myoblasts 
reduces intensity of SOCE to the control level.  
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Data presented here contest the conventional belief that mutations in dystrophin-encoding gene do not  
affect undifferentiated muscle cells. In all the experiments in this study, wild type and dystrophic  
myoblasts were tested outside their respective muscle environments, following a period of culture in  
vitro and so all the observed differences must have an intrinsic origin. The only difference between  
these cells is the presence or absence of the fully-functional Dmd gene. Therefore, results presented  
here add to a set of data challenging the current belief that mutations in this dystrophin-encoding gene  
do not affect undifferentiated muscle cells but only differentiated myotubes and myofibres. In contrast  
with this dogma, several studies conducted by us and others showed that dystrophic myoblasts  
similarly as in the case of lymphoblasts differ from wild type cells [4, 5, 34, 45]. For example, mdx  
myoblasts have altered expression and function of P2X7 receptors, leading to abnormal Ca2+ influx,  
ERK phosphorylation [4,5] and triggering a unique mechanism of autophagic cell death [6]. Moreover,  
dystrophin knockdown in adult muscles did not produce any pathology indicating that early dystrophin  
expression is crucial [46].  Indeed, examination of myogenesis revealed that this pathology starts in  
embryonic development arising from the loss stem cell. Thus, dystrophin expression appears to be  
essential for emergent stem cell function(s) and it has been shown that its absence alters myoblast  
differentiation processes [47] and their energy homeostasis [36]  
DMD studies have been conducted using myotubes or myofibers, which reflected observations that 
while myoblasts contain dystrophin transcripts, these cells have little or any detectable protein [48, 49, 
50]. Therefore, no phenotypic consequences of the protein absence due to mutations in the 
dystrophin gene were to be expected. Contrary to this, Ferrari et al., (1994) showed that DMD 
lymphoblasts (also expressing mRNA but with undetectable dystrophin protein levels) are more 
susceptible to ATP damage [34], exactly as the dystrophic myoblasts are. It is currently not known 
whether these effects are mediated by the residual protein or dystrophin mRNA-dependent regulatory 
pathways: An interesting alternative to the structural/scaffolding role of a trace amounts  of 
dystrophin protein could be that the dystrophin transcript, which is absent in mdx cells due to 
nonsense-mediated decay, plays an important regulatory role in myoblasts.  
To conclude, data described hitherto indicate that mutation in the dystrophin-encoding gene results in 
multiple phenotypic alterations that extend beyond structural stability of muscle fibre sarcolemma and 
clearly can also demonstrate as early as in undifferentiated myoblasts. The increased SOCE due to 
enhanced STIM1 level together with purinergic abnormalities occurring in dystrophic myoblasts could 
affect muscle regeneration and thus exacerbate the disease phenotype.  
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FIGURE LEGENDS  
 
 
Fig. 1 Characterisation of immortalised muscle cell lines  
Desmin immunodetection (green, top row panels) at specific time points (days) during the in vitro 
differentiation process illustrates the myogenic potential of immorto cell lines. Bottom panels 
show corresponding bright field images.  
 
Fig. 2. Ca2+ response to ATP stimulation in immortalized wild type (w/t) and dystrophic 
(mdx) myoblasts  
Representative traces  from  one typical  experiment  out  of six:  A.  in  the absence of 
extracellular Ca2+; B. in the presence of 2 mM CaCl2 in the assay Concentrations used: ATP - 
1 mM; CBB - 1 M.  
Fig.  3.  Store-operated  Ca2+  entry  and  changes  in  NCX  and  SERCA content  in  
immortalized (w/t) and dystrophic (mdx) myoblasts  
Cells  incubated  in  the Ca2+-free  buffered  saline  solution  were  treated  with  100  nM  
thapsigargin. After [Ca2+]c recovery 2 mM CaCl2 was added to the assay. A. Representative  
traces from one experiment out of 15; B. Mean rate of [Ca2+]c increase after addition of  
CaCl2.calculated as a slope of the initial part of the curve. Data show mean value ± SD from  
15 independent experiments. * p < 0.01. C. Representative Western blotting of IP3; one  out  
of 3 independent experiments. D. Western blotting analysis of NCX protein. Bottom bands  
represent protein loading controls (-actin). A representative result from one out of 3  
experiments is shown. E and F. Western blotting analysis of SERCA1 and SERCA2 proteins, 
respectively. Shown are representative results from one of 3 independent experiments and 
respective mean values normalised to -actin ± SD. p < 0.003.  
 
Fig.  4. Half-time necessary to attain a new steady state after the store-operated  
dependent calcium transient and rate of Ca2+ extrusion from cells in w/t and mdx  
immortalized myoblasts  
A. A conceptual schematics showing how the half time of recovering the new  was calculated  
B. A half time for a new [Ca2+]c steady state to be achieved  
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C. Initial rate of calcium efflux calculated as a slope of the initial part of curve after the maximal  
 [Ca2+]c was reached.  
B and C:  Mean values ±  SD for 15 independent experiments. * p < 0.003, ** p < 0.05.  
 
Fig. 5. STIM1 analyses in (w/t) and dystrophic (mdx) immortalized myoblasts  
A. One representative Western blot out of 15 showing the relative amounts of STIM1 protein.  
B.  Mean STIM1 protein levels in control (assumed as 100%) and mdx myoblasts, expressed in a 
relation to actin, based on the data from 15 independent experiments; Data show mean value ± 
SD for the Western blots data obtained with the use of antibodies specific to the N- 
terminus of STIM1 protein. *p < 0.004 C. Agarose gel image representative of results 
obtained in semi-quantitative RT-PCR for STIM1 mRNA.  
 
Fig. 6 Orai1 and TRPC proteins level in (w/t) and dystrophic (mdx) immortalized 
myoblasts 
A. Representative single Western blot out of 10 showing the relative amount of Orai1 protein  
 and mean value ± SD. Western blot data obtained with the use of antibodies specific to the  
 N-terminus of Orai1 protein.  
B.  Representative single Western blot out of 3 showing the relative amounts of TRPC1,  
 TRPC3 and TRPC6 proteins and mean values ±  SD  for these independent experiments.  
 * p < 0.03  
 
Fig. 7. Store-operated Ca2+ entry into primary w/t and mdx myoblasts derived from 
various muscles  
Cells  incubated  in  the Ca2+-free  buffered  saline  solution  were  treated  with  100  nM  
thapsigargin. After [Ca2+]c recovery, 2 mM CaCl2 was added to the assay. A. representative 
traces from one experiment out of 5.  B. Mean rate of [Ca2+]c increase after addition of CaCl2, 
calculated as a slope of the initial part of the curve; Data show mean value ± SD from 5 
independent experiments. * p < 0.03. C. Western blot analyses of STIM1 levels in myoblast 
derived from various muscles: Sol, Soleus; TA, Tibialis anterior. Representative data from two 
experiments out of 5 are shown.  
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